Increased prolidase activity in Alzheimer's dementia: A case-control study

Area of Science:

• Biochemistry
• Neuroscience
• Enzymology

Background:

• Collagen metabolism involves the prolidase enzyme, crucial for extracellular matrix (ECM) integrity.
• Alterations in ECM and synaptic connectivity are implicated in Alzheimer's disease (AD) pathogenesis.
• Understanding enzyme activity in AD may reveal novel therapeutic targets.

Purpose of the Study:

• To investigate the activity of prolidase enzyme in Alzheimer's disease (AD) patients.
• To determine the correlation between prolidase activity and cognitive function in AD.
• To explore the potential role of prolidase in AD-associated cognitive deficits.

Main Methods:

• Enzyme activity assays were performed on subjects with AD and a control group.
• Prolidase activity levels were quantified (U/mL).
• Cognitive function was assessed using the Mini-Mental State Examination (MMSE) and correlated with enzyme activity.

Main Results:

• Prolidase activity was significantly higher in AD subjects (5.62 ± 2.05 U/mL) compared to controls (4.45 ± 0.92 U/mL) (p = 0.0016).
• Elevated prolidase activity was observed even in mild AD stages (p = 0.006).
• A significant inverse correlation was found between prolidase activity and MMSE scores (p = 0.0344).

Conclusions:

• Increased prolidase activity is associated with Alzheimer's disease.
• Prolidase-mediated changes in the extracellular matrix may contribute to cognitive impairment in AD.
• Further research into prolidase's role could offer insights into AD progression and treatment.